QIU Shun-hui, ZHANG Chang-hua, GAO Shu-liang, et al. Anti-atherosclerosis Effect of Buyang Huanwu Decoction Relates with Connexins[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(18): 161-165.
DOI:
QIU Shun-hui, ZHANG Chang-hua, GAO Shu-liang, et al. Anti-atherosclerosis Effect of Buyang Huanwu Decoction Relates with Connexins[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(18): 161-165. DOI: CNKI:11-3495/R.20110721.1733.003.
Anti-atherosclerosis Effect of Buyang Huanwu Decoction Relates with Connexins
Objective: To study the possible link between preventing effect of Buyang Huanwu decoction (BHD) for atherosclerosis (AS) with connexins (Cx). Method: Thorty-two male ApoE-/- mice were randomly divided into four groups: model group and three dose groups of BHD (5
10
20 g ·kg-1 ·d-1). C57BL/6J mice was used to set up a normal control group. AS model was established by intragastric administration of homocysteine (0.1 g ·kg-1 ·d-1). Meanwhile
treatment groups were intragastric administrated with BHD (5
10
20 g ·kg-1 ·d-1). Eight weeks later
the area of atherosclerotic plaques
blood vessel walls and the ratio between them were observed and measured. The aortic ROS content and the expression of MAPKp38
ERK
Cx37
Cx43 were determined. Result: Model group showed evident AS lesions differently to the three treatment groups. The model group ROS content was elevated (17.01±1.31) ×105 RFU
compared with that in control group (2.73±0.18)×105 RFU
showing significant difference (P< 0.01). The MAPKp38
ERK
Cx43 protein expressions were significantly elevated
while Cx37 decreased in the models. Different doses of BHD could decrease ROS content
down-regulate MAPKp38
ERK
Cx43 protein expressions
and up-regulate Cx37 expression. Conclusion: BHD could prevent atherosclerosis induced by homocysteine via preventing AMPKs and regulating connexin expression.
Relationship Between Anti-atherosclerosis Efffect and Tight Junction Protein by Buyang Huanwu Tang
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Effect of Co-treatment Method of Stagnation of Phlegm and Blood Stasis (Danlou Tablet) on Vascular Endothelial Function in Patients with Atherosclerosis
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Related Author
LIU Yu-hui
YI Wen-feng
YOU Yu
SONG Wei
ZHANG Zhongyi
QIU Hairong
ZHAO Mei
ZHOU Zubing
Related Institution
Chengdu University of Traditional Chinese Medicine(TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences
Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine